rs1051931 Nonsynonymous Polymorphism of Platelet-Activating Factor Acetylhydrolase Gene PLA2G7 Is Associated with Dysesthesia and Pain Severity After Surgery
- PMID: 40362172
- PMCID: PMC12071393
- DOI: 10.3390/ijms26093931
rs1051931 Nonsynonymous Polymorphism of Platelet-Activating Factor Acetylhydrolase Gene PLA2G7 Is Associated with Dysesthesia and Pain Severity After Surgery
Abstract
Platelet-activating factor (PAF) is a potent inflammatory mediator that activates the PAF receptor, which induces additional PAF production. Animal studies have shown that PAF induces inflammatory and neuropathic pain, including dysesthesia, a prodromal symptom of neuropathic pain. However, in humans, the association between PAF and pain remains unknown. Phospholipase A2 Group VII (PLA2G7) hydrolyzes PAF to eliminate PAF activity. The present study investigated the association between the PLA2G7 rs1051931 nonsynonymous polymorphism (T/C, Val379Ala), which decreases the PAF-degrading activity of PLA2G7 in plasma, and postoperative pain-related phenotypes in humans. The study included 303 patients who underwent sagittal split ramus osteotomy at Tokyo Dental College and were assessed for dysesthesia and 332 patients who underwent laparoscopic gynecologic surgery at Juntendo University Hospital and were assessed for postoperative pain using the Numeric Rating Scale (NRS). PLA2G7 rs1051931 was significantly associated with dysesthesia (p = 0.0491) and NRS scores (p = 0.0243). Carriers of the CC genotype of PLA2G7 rs1051931 were more likely to have dysesthesia and higher NRS scores than carriers of the TT + TC genotypes. Carriers of the CC genotype of PLA2G7 rs1051931 reportedly had lower PAF-degrading activity in plasma, thereby increasing the amount of PAF. The increase in PAF possibly leads to dysesthesia and postoperative pain in humans.
Keywords: PAF; PAF-AH; PLA2G7; SNP; dysesthesia; postoperative pain.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.Pregnancy Hypertens. 2020 Apr;20:19-26. doi: 10.1016/j.preghy.2020.02.005. Epub 2020 Feb 26. Pregnancy Hypertens. 2020. PMID: 32145524
-
Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.Acta Pharmacol Sin. 2016 Nov;37(11):1442-1448. doi: 10.1038/aps.2016.90. Epub 2016 Sep 19. Acta Pharmacol Sin. 2016. PMID: 27641736 Free PMC article.
-
Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.Hum Reprod. 2010 May;25(5):1288-94. doi: 10.1093/humrep/deq047. Epub 2010 Feb 25. Hum Reprod. 2010. PMID: 20185515
-
[Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].Brain Nerve. 2008 Nov;60(11):1319-24. Brain Nerve. 2008. PMID: 19069165 Review. Japanese.
-
Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).Cardiovasc Drugs Ther. 2009 Feb;23(1):73-83. doi: 10.1007/s10557-008-6133-8. Epub 2008 Oct 24. Cardiovasc Drugs Ther. 2009. PMID: 18949548 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous